Check out the FAQ,Terms of Service & Disclaimers by clicking the
link. Please register
to be able to post. By viewing this site you are agreeing to our Terms of Service and Acknowledge our Disclaimers.
FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster.
The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website.
By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.
Announcement
Collapse
No announcement yet.
Pfizer recalls birth control pills in US because they may not work
Pfizer recalls birth control pills in US because they may not work
National Interest - US
Pfizer recalls birth control pills in US because they may not work
Published February 01, 2012 | NewsCore
NEW YORK ? Pharmaceutical giant Pfizer on Tuesday announced a recall of some birth control pills in the United States, because they may not contain enough contraceptive to prevent pregnancy.
Pfizer said the birth control pills posed no health threat to women but urged consumers affected by the recall to "begin using a non-hormonal form of contraception immediately."
Re: Pfizer recalls birth control pills in US because they may not work
Pfizer Announces Voluntary Nationwide Recall of Lo/Ovral?-28 and Norgestrel/Ethinyl Estradiol Tablets Due to Possibility of Inexact Tablet Counts or Out of Sequence Tablets
Contact:
Consumer:1-877-509-3935
Media:Grace Ann Arnold ? Media
(845) 602-4768 Graceann.Arnold@Pfizer.com
FOR IMMEDIATE RELEASE - January 31, 2012 - NEW YORK, N.Y. ? Pfizer Inc. announced today that it has voluntarily recalled 14 lots of Lo/Ovral?-28 (norgestrel and ethinyl estradiol)Tablets and 14 lots of Norgestrel and Ethinyl Estradiol Tablets (generic) for customers in the U.S. market. An investigation by Pfizer found that some blister packs may contain an inexact count of inert or active ingredient tablets and that the tablets may be out of sequence. The cause was identified and corrected immediately.
These products are oral contraceptives indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. These tablets were manufactured and packaged by Pfizer Inc., commercialized by Akrimax Rx Products and labeled under the Akrimax Pharmaceuticals brand. This product is distributed to warehouses, clinics and retail pharmacies nationwide.
As a result of this packaging error, the daily regimen for these oral contraceptives may be incorrect and could leave women without adequate contraception, and at risk for unintended pregnancy. These packaging defects do not pose any immediate health risks. However, consumers exposed to affected packaging should begin using a non-hormonal form of contraception immediately. Patients who have the affected product (lot numbers are provided below) should notify their physician and return the product to the pharmacy.
These products are packaged in blister packs containing 21 tablets of active ingredients and seven tablets of inert ingredients. Correct dosing of this product is important in avoiding the associated risks of an unplanned pregnancy. Correctly packaged blister packs are pictured here.
Any adverse events that may be related to the use of these products should be reported to Akrimax Medical Information at 1-877-509-3935 (8 AM to 7 PM Mon-Fri CST) or to FDA's Med Watch Program either online, by regular mail or by fax.
Pfizer has responded rapidly to ensure that its products continue to meet the company?s high quality standards. The safety of patients who take our medicines is our first priority.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Lot numbers of affected packs of Lo/Ovral?-28 (norgestrel and ethinyl estradiol)Tablets and Norgestrel and Ethinyl Estradiol Tablets (generic) follow on the table below:
Pfizer Announces Voluntary Nationwide Recall of Lo/Ovral?-28 and Norgestrel/Ethinyl Estradiol Tablets Due to Possibility of Inexact Tablet Counts or Out of Sequence Tablets Photos
Tweet
Comment